The 5-HT1A receptor in schizophrenia: a promising target for novel atypical neuroleptics? (Q33845251)

29 July 2017

1 reference

title

The 5-HT1A receptor in schizophrenia: a promising target for novel atypical neuroleptics? (English)

1 reference

29 July 2017

0 references

J F Deakin

2

0 references

author name string

R A Bantick

series ordinal

1

1 reference

29 July 2017

P M Grasby

series ordinal

3

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 March 2001

1 reference

Journal of Psychopharmacology

29 July 2017

published in

1 reference

29 July 2017

volume

15

1 reference

29 July 2017

issue

1

1 reference

29 July 2017

page(s)

37-46

1 reference

Prevention by ( /-)-8-hydroxy-2-(di-n-propylamino)tetralin of both catalepsy and the rises in rat striatal dopamine metabolism caused by haloperidol

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1177/026988110101500108

(R)-8-OH-DPAT preferentially increases dopamine release in rat medial prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/026988110101500108

The 5-HT1A receptor selective ligands, (R)-8-OH-DPAT and (S)-UH-301, differentially affect the activity of midbrain dopamine neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/026988110101500108

Effects of antipsychotic drugs on dopamine and serotonin contents and metabolites, dopamine and serotonin transporters, and serotonin1A receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/026988110101500108

Electrophysiological evidence for a functional interaction between 5-HT1A and 5-HT2A receptors in the rat medial prefrontal cortex: an iontophoretic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/026988110101500108

A review of central 5-HT receptors and their function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/026988110101500108

Facilitation of dopamine release in vivo by serotonin agonists: studies with microdialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/026988110101500108

Mirtazapine enhances the effect of haloperidol on apomorphine-induced climbing behaviour in mice and attenuates haloperidol-induced catalepsy in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/026988110101500108

The distribution of 5-HT1A and 5-HT2A receptor mRNA in human brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/026988110101500108

5-HT1A and 5-HT2A receptor mRNAs and binding site densities are differentially altered in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/026988110101500108

[3H]WAYâ 100635 for 5â HT1A receptor autoradiography in human brain: a comparison with [3H]8â OHâ DPAT and demonstration of increased binding in the frontal cortex in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/026988110101500108

Perspectives on the role of serotonergic mechanisms in the pharmacology of schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/026988110101500108

Postsynaptic 5-HT1A receptors control 5-HT release in the rat medial prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/026988110101500108

Reversal of haloperidol-induced extrapyramidal side effects in cebus monkeys by 8-hydroxy-2-(di-n-propylamino)tetralin and its enantiomers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/026988110101500108

Ziprasidone 80 mg/day and 160 mg/day in the acute exacerbation of schizophrenia and schizoaffective disorder: a 6-week placebo-controlled trial. Ziprasidone Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/026988110101500108

A two-process theory of schizophrenia: Evidence from studies in post-mortem brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/026988110101500108

Familial and developmental abnormalities of front lobe function and neurochemistry in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/026988110101500108

No change in the density of the serotonin1A receptor, the serotonin4 receptor or the serotonin transporter in the dorsolateral prefrontal cortex from subjects with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/026988110101500108

5-HT1A receptor agonists: recent developments and controversial issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/026988110101500108

Is the potent 5-HT1A receptor agonist, alnespirone (S-20499), affecting dopaminergic systems in the rat brain?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/026988110101500108

The emergin role of clozapine in the treatment of movement disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/026988110101500108

Extrapyramidal symptoms during long-term treatment with antipsychotics: special focus on clozapine and D1 and D2 dopamine antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/026988110101500108

Simultaneous quantification of serotonin, dopamine and noradrenaline levels in single frontal cortex dialysates of freely-moving rats reveals a complex pattern of reciprocal auto- and heteroreceptor-mediated control of release

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/026988110101500108

Modulation of dialysate levels of dopamine, noradrenaline, and serotonin (5-HT) in the frontal cortex of freely-moving rats by (-)-pindolol alone and in association with 5-HT reuptake inhibitors: comparative roles of beta-adrenergic, 5-HT1A, and 5-H

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/026988110101500108

Serotonin (5-HT)2A receptor activation enhances dialysate levels of dopamine and noradrenaline, but not 5-HT, in the frontal cortex of freely-moving rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/026988110101500108

Alterations in the cortical serotonergic system in schizophrenia: A postmortem study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/026988110101500108

Role of the medial prefrontal cortex in 5-HT1A receptor-induced inhibition of 5-HT neuronal activity in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/026988110101500108

[3H]8-hydroxy-2-(di-n-propylamino)tetralin binding to pre- and postsynaptic 5-hydroxytryptamine sites in various regions of the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/026988110101500108

The effect of ipsapirone and S(-)-pindolol on dopamine release in rat striatum and nucleus accumbens

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/026988110101500108

8-Hydroxy-2-(di-n-propylamino) tetralin, a selective serotonin1A receptor agonist, blocks haloperidol-induced catalepsy by an action on raphe nuclei medianus and dorsalis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/026988110101500108

Serotonin uptake sites and serotonin receptors are altered in the limbic system of schizophrenics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/026988110101500108

Serotonin-dopamine interaction and its relevance to schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/026988110101500108

Drug treatment of the negative symptoms of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/026988110101500108

Dopamine, the prefrontal cortex and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/026988110101500108

Induction of burst firing in ventral tegmental area dopaminergic neurons by activation of serotonin (5-HT)1A receptors: WAY 100,635-reversible actions of the highly selective ligands, flesinoxan and S 15535.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/026988110101500108

8-OH-DPAT, a 5-HT1A agonist and ritanserin, a 5-HT2A/C antagonist, reverse haloperidol-induced catalepsy in rats independently of striatal dopamine release

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/026988110101500108

Clozapine has sub-micromolar affinity for 5-HT1A receptors in human brain tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/026988110101500108

The role of serotonin in antipsychotic drug action

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/026988110101500108

Decreased serotonin S2 and increased dopamine D2 receptors in chronic schizophrenics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/026988110101500108

Agonist and antagonist actions of antipsychotic agents at 5-HT1A receptors: a [35S]GTPgammaS binding study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/026988110101500108

Advances in psychopharmacology--schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/026988110101500108

Serotonin receptors in the human brain--III. Autoradiographic mapping of serotonin-1 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/026988110101500108

Effects of dopamine antagonists in a two-way active avoidance procedure in rats: interactions with 8-OH-DPAT, ritanserin, and prazosin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/026988110101500108

Attenuation of haloperidol-induced catalepsy by a 5-HT2C receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/026988110101500108

Clozapine increases dopamine release in prefrontal cortex by 5-HT1A receptor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/026988110101500108

5-HT(1A) receptor activation contributes to ziprasidone-induced dopamine release in the rat prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/026988110101500108

Influence of serotoninergic drugs on in vivo dopamine extracellular output in rat striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/026988110101500108

Comparison of the novel antipsychotic ziprasidone with clozapine and olanzapine: inhibition of dorsal raphe cell firing and the role of 5-HT1A receptor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/026988110101500108

Serotonin1A receptors are increased in postmortem prefrontal cortex in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/026988110101500108

Effect of adjunctive treatment with serotonin-1A agonist tandospirone on memory functions in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/026988110101500108

Increase of extracellular dopamine in the prefrontal cortex: a trait of drugs with antidepressant potential?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/026988110101500108

Serotonergic mechanisms in neuroleptic-induced catalepsy in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/026988110101500108

A BIOCHEMICAL AND PHARMACOLOGICAL SUGGESTION ABOUT CERTAIN MENTAL DISORDERS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/026988110101500108

Regulation of nucleus accumbens dopamine release by the dorsal raphe nucleus in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/026988110101500108

Autoradiography with [3H]8-OH-DPAT reveals increases in 5-HT1A receptors in ventral prefrontal cortex in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/026988110101500108

10.1177/026988110101500108

21 January 2018

Identifiers

DOI

1 reference

29 July 2017

1 reference